Kyrgyzstan vs Tanzania: Average non-HDL cholesterol levels
Kyrgyzstan
3.2
in 2018
Tanzania
3.2
in 2018
Kyrgyzstan rank
118th
Tanzania rank
118th
Average non-HDL cholesterol levels over time
- Kyrgyzstan
- Tanzania
How they compare
Kyrgyzstan currently reports 3.2 against 3.2 in Tanzania, a difference of 0.
The two have swapped places 3 times across 39 shared years of data; in 1980 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 118th and Tanzania ranks 118th of 191 countries.
Kyrgyzstan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.1 | 2.63 | 0.47 | Kyrgyzstan |
| 1990s | 3.1 | 2.73 | 0.37 | Kyrgyzstan |
| 2000s | 3.1 | 2.89 | 0.21 | Kyrgyzstan |
| 2010s | 3.16 | 3.11 | 0.0444 | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Kyrgyzstan or Tanzania?
- Kyrgyzstan, at 3.2 against 3.2 in Tanzania as of 2018.
- What is the difference in average non-hdl cholesterol levels between Kyrgyzstan and Tanzania?
- 0, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Tanzania?
- 39 years are reported by both, from 1980 to 2018.
- How do Kyrgyzstan and Tanzania rank globally for average non-hdl cholesterol levels?
- Kyrgyzstan ranks 118th and Tanzania ranks 118th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.